
CAS 356068-97-8
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
9 Produkte.
Desethyl Sunitinib ((Z)-N-(2-(ethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide)
CAS:Lactams, nesoiFormel:C20H23FN4O2Farbe und Form:Orange SolidMolekulargewicht:370.1805N-Desethylsunitinib
CAS:Kontrolliertes ProduktFormel:C20H23FN4O2Farbe und Form:NeatMolekulargewicht:370.42N-Desethyl Sunitinib
CAS:N-Desethyl Sunitinib (SU012662) is inhibitor of tyrosine kinases tumor proliferation and angiogenesis, including VEGFR, PDGFR, KIT, and FLT3,Formel:C20H23FN4O2Reinheit:98%Farbe und Form:SolidMolekulargewicht:370.42N-Desethyl sunitinib
CAS:<p>N-Desethyl sunitinib is an active metabolite of sunitinib. It has been shown to have antitumor response in experimental models, suggesting that it may be a potential biomarker for renal cell cancer. Sunitinib is used in the treatment of cancers such as renal cell cancer and gastrointestinal stromal tumor. N-Desethyl sunitinib has also been shown to affect drug metabolism through the induction of CYP3A4 and CYP2D6, which can lead to drug interactions. This metabolite is detected in human serum by high performance liquid chromatography with a matrix effect analyzer, but not by LC-MS/MS.</p>Formel:C20H23FN4O2Reinheit:Min. 95 Area-%Farbe und Form:PowderMolekulargewicht:370.42 g/molN-Desethyl Sunitinib-d4 Maleate
CAS:Kontrolliertes Produkt<p>Applications N-Desethyl Sunitinib-d4 Maleate, is the labeled analogue of N-Desethyl Sunitinib (D289650), a metabolite of Sunitinib (S820000).<br>References Sun, L., et al.: J. Med. Chem., 46, 1116 (2003), Mendel, D.B., et al.: Clin. Cancer Res., 9, 327 (2003), Sistla, A., et al.: Drug Dev. Ind. Pharm., 30, 19 (2004), Sakamoto, K.M., et al.: Curr. Opin. Invest. Drugs, 5. 1329 (2004),<br></p>Formel:C20H19D4FN4O2•C4H4O4Farbe und Form:NeatMolekulargewicht:347.4511607









